Discovering the connection between familial and sporadic amyotrophic lateral sclerosis: Pathology trumps genetics

Future Neurology

Volumn 5, Issue 5, 2010, Pages 625-628

  Fecto, Faisal ^a   Deng, Han Xiang ^a   Siddique, Teepu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

amyotrophic lateral sclerosis; FUS; neurodegeneration; optineurin; protein aggregation; SOD1; TDP 43; ubiquitin

Indexed keywords

DNA BINDING PROTEIN; GENE PRODUCT; OPTINEURIN; PROTEIN FUS; SUPEROXIDE DISMUTASE; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; DISEASE CLASSIFICATION; EDITORIAL; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; FAMILY HISTORY; GENE AMPLIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC EPIGENESIS; HUMAN; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROCESSING; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS;

EID: 77957130782     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/fnl.10.47     Document Type: Editorial

References (25)

1. Deng HX, Hentati A, Tainer JA et al.: Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261, 1047-1051 (1993).
2. Rosen DR, Siddique T, Patterson D et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
3. Pasinelli P, Brown RH: Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710-723 (2006).
4. Valdmanis PN, Rouleau GA: Genetics of familial amyotrophic lateral sclerosis. Neurology 70, 144-152 (2008).
5. Valdmanis PN, Daoud H, Dion PA, Rouleau GA: Recent advances in the genetics of amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep. 9, 198-205 (2009).
6. Ticozzi N, LeClerc AL, Keagle PJ et al.: Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann. Neurol. 68, 102-107 (2010).
7. Maruyama H, Morino H, Ito H et al.: Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223-226 (2010).
8. Siddique T: What is missing in ALS. Lancet Neurol. 7, 289-290 (2008).
9. Neumann M, Sampathu DM, Kwong LK et al.: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 (2006).
10. Hasegawa M, Arai T, Nonaka T et al.: Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70 (2008).
11. Mackenzie IR, Bigio EH, Ince PG et al.: Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427-434 (2007).
12. Kabashi E, Valdmanis PN, Dion P et al.: TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574 (2008).
13. Sreedharan J, Blair IP, Tripathi VB et al.: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672 (2008).
14. Gijselinck I, Sleegers K, Engelborghs S et al.: Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol. Aging 30, 1329-1331 (2009).
15. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL et al.: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 (2009).
16. Vance C, Rogelj B, Hortobagyi T et al.: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 (2009).
17. Deng HX, Zhai H, Bigio EH et al.: FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 67, 739-748 (2010).
18. Lagier-Tourenne C, Polymenidou M, Cleveland DW: TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46-R64 (2010).
19. Gurney ME, Pu H, Chiu AY et al.: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775 (1994).
20. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH: TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 106, 18809-18814 (2009).
21. Wils H, Kleinberger G, Janssens J et al.: TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA 107, 3858-3863 (2010).
22. Zhou H, Huang C, Chen H et al.: Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 6, E1000887 (2010).
23. Li Y, Ray P, Rao EJ et al.: A Drosophila model for TDP-43 proteinopathy. Proc. Natl Acad. Sci. USA 107, 3169-3174 (2010).
24. Ash PE, Zhang YJ, Roberts CM et al.: Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum. Mol. Genet. 19(16), 3206-3218 (2010).
25. Hicks GG, Singh N, Nashabi A et al.: FUS deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 24, 175-179 (2000).